SW 780

• Description:

  The SW 780 line was established in 1974 by A. Leibovitz from a grade I transitional cell carcinoma. The patient had preoperative chemotherapy (Thiotepa). The cells have a reported plating efficiency of 41%.

• Applications:

  For research use only

• Storage Conditions:

  Liquid Nitrogen